← FDA DRUG APPROVALS

FDA ANDA · ANDA089158

METHOTREXATE SODIUM

Sponsor: PHARMACHEMIE USA

APPLICATION
ANDA089158
TYPE
ANDA
ORIGINAL APPROVAL
1988-07-08
LATEST ACTION
1992-04-07
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

METHOTREXATE SODIUMDiscontinued
METHOTREXATE SODIUM EQ 25MG BASE/ML · INJECTABLE · INJECTION

Approval history

1992-04-07Manufacturing (CMC) · Supplement 4AP
1992-02-18Labeling · Supplement 5AP
1988-10-05Manufacturing (CMC) · Supplement 1AP
1988-07-08OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →